Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells

por Mahalingam, D, Natoni, A, Keane, M, Samali, A, Szegezdi, E
Publicado 2010

Targeting the Pim kinases in multiple myeloma

por Keane, N A, Reidy, M, Natoni, A, Raab, M S, O'Dwyer, M
Publicado 2015

Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants

por Reis, C R, van der Sloot, A M, Natoni, A, Szegezdi, E, Setroikromo, R, Meijer, M, Sjollema, K, Stricher, F, Cool, R H, Samali, A, Serrano, L, Quax, W J
Publicado 2010

P861: SIALOFUCOSYLATED STRUCTURES ENABLE PLATELET BINDING TO MYELOMA CELLS CONFERRING PROTECTION FROM NK-MEDIATED CYTOTOXICITY

por Natoni, A., Cerreto, M., De Propris, M. S., Petrucci, M. T., Del Giudice, I., Intoppa, S., Milani, M. L., Kirkham-McCarthy, L., Henderson, R., Swan, D., O’Dwyer, M., Guarini, A., Foà, R.
Publicado 2022

E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271

por Natoni, A, Smith, T A G, Keane, N, McEllistrim, C, Connolly, C, Jha, A, Andrulis, M, Ellert, E, Raab, M S, Glavey, S V, Kirkham-McCarthy, L, Kumar, S K, Locatelli-Hoops, S C, Oliva, I, Fogler, W E, Magnani, J L, O'Dwyer, M E
Publicado 2017